Comparing the current results to its competitors, P3 Health Partners Inc reported Revenue increase in the 2 quarter 2026 by 8.6 % year on year. The revenue growth was below P3 Health Partners Inc 's competitors' average revenue growth of 11.69 %, achieved in the same quarter.
P3 Health Partners Inc 's Comment on Competition and Industry Peers
The company operates within a competitive and fragmented healthcare industry, primarily contending with the fee-for-service (FFS) model prevalent in much of the healthcare system. It faces competition in areas such as reimbursement structures and the recruitment of payors and physician partners. Competitors include large and medium-sized local and national companies offering care under various models. Key competitors in the population health management sector include Aledade, Astrana Health, and agilon health, as well as numerous local provider networks, hospitals, and health systems. Additionally, large payors have developed managed care service tools, sometimes providing these services at discounted rates or expanding relationships with competing physicians or networks. Some competitors also offer specialized services like data analytics or disease-based programs to support value-based care arrangements. Competitive dynamics vary by geography, and new entrants may emerge, potentially affecting the company's growth strategy and operations.
Lifestance Health Group Inc is a mental health care company that provides comprehensive outpatient services. Their business model focuses on delivering personalized, evidence-based treatments to individuals struggling with various mental health conditions. They aim to optimize patient outcomes by employing a collaborative, integrated approach that combines therapy, medication management, and innovative technology solutions.
Humana Inc.s business model focuses on providing a wide range of health insurance products and healthcare services to individuals and groups. The company generates revenue primarily through the sale of Medicare, Medicaid, and commercial insurance plans, as well as by operating healthcare facilities and clinics. Their mission is to enhance customer health outcomes by delivering accessible, affordable, and integrated healthcare solutions tailored to the needs of their members.
Agilon Health Inc operates on a value-based care model, partnering with healthcare providers to enhance the quality of care for their patients. The company works closely with physicians and health systems, empowering them with data-driven insights and innovative strategies to improve patient outcomes and reduce costs. Agilon Health's business model revolves around supporting healthcare providers in their transition to value-based care and delivering comprehensive, personalized care to patients.
Heart Test Laboratories Inc operates as a medical diagnostic company that specializes in heart testing. Their business model revolves around providing innovative and accurate cardiovascular diagnostic tests to healthcare facilities and patients, aimed at early detection and prevention of heart diseases. They achieve this by leveraging advanced technology, collaborating with medical professionals, and offering their services through partnerships with hospitals, clinics, and physicians.
Sources:
P3 Health Partners Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on P3 Health Partners Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.